These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 21948927)

  • 1. Complex visual hallucinations, presumably due to subarachnoid hemorrhage, treated successfully with risperidone.
    Spiegel DR; Petersen T
    J Neuropsychiatry Clin Neurosci; 2011; 23(3):E44. PubMed ID: 21948927
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible risperidone-induced tardive dystonia.
    Narendran R; Young CM; Pato MT
    Ann Pharmacother; 2000 Dec; 34(12):1487-8. PubMed ID: 11144710
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypotension and orthostasis following a risperidone overdose.
    Himstreet JE; Daya M
    Ann Pharmacother; 1998 Feb; 32(2):267. PubMed ID: 9496415
    [No Abstract]   [Full Text] [Related]  

  • 4. Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials.
    Wooltorton E
    CMAJ; 2002 Nov; 167(11):1269-70. PubMed ID: 12451085
    [No Abstract]   [Full Text] [Related]  

  • 5. [Malignant neuroleptic syndrome associated to risperidone].
    Aguirre C; García Monco JC; Mendibil B
    Med Clin (Barc); 1998 Feb; 110(6):239. PubMed ID: 9547739
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome with risperidone.
    Gleason PP; Conigliaro RL
    Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pavor nocturnus as a side effect of a single daily risperidone dose.
    Prueter C; Luecke FG; Hoff P
    Gen Hosp Psychiatry; 2005; 27(4):300-1. PubMed ID: 15993264
    [No Abstract]   [Full Text] [Related]  

  • 8. Tardive dyskinesia in a pregnant woman with low dose, short-duration risperidone: possible role of estrogen-induced dopaminergic hypersensitivity.
    Chatterjee B; Sharan P
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):E44-6. PubMed ID: 24515710
    [No Abstract]   [Full Text] [Related]  

  • 9. Risperidone augmentation with amisulpride: the blue-tongue sign.
    Yun HW; Lee BD
    Psychiatry Clin Neurosci; 2012 Aug; 66(5):464-5. PubMed ID: 22834673
    [No Abstract]   [Full Text] [Related]  

  • 10. Elderly nursing home resident with head drop.
    Abel Boenerjous RS; Zirker W; Masilamani S
    J Am Med Dir Assoc; 2015 May; 16(5):433-4. PubMed ID: 25748817
    [No Abstract]   [Full Text] [Related]  

  • 11. Risperidone induced oedema in a child with learning disability and autism.
    Feroz-Nainar C; Selvaraj P; Roy M
    Autism; 2006 May; 10(3):308-10. PubMed ID: 16682401
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperprolactinemia induced by neuroleptics].
    Lakartidningen; 2007 May 9-15; 104(19):1522. PubMed ID: 17550031
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D(2) receptor occupancy.
    Yamada Y; Ohno Y; Nakashima Y; Fukuda M; Takayanagi R; Sato H; Tsuchiya F; Sawada Y; Iga T
    Synapse; 2002 Oct; 46(1):32-7. PubMed ID: 12211096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable sustained-release risperidone: recurrence of delirium and treatment failure.
    Prescrire Int; 2006 Oct; 15(85):183. PubMed ID: 17131515
    [No Abstract]   [Full Text] [Related]  

  • 16. Risperidone treatment of complex hallucinations in a patient with posterior cortical atrophy.
    Campbell JJ; Ngo G
    J Neuropsychiatry Clin Neurosci; 2008; 20(3):378-9. PubMed ID: 18806250
    [No Abstract]   [Full Text] [Related]  

  • 17. Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patients.
    Gassó P; Mas S; Oliveira C; Bioque M; Parellada E; Bernardo M; Trias G; Comeche J; Lafuente A
    Eur Neuropsychopharmacol; 2011 Apr; 21(4):294-9. PubMed ID: 20619616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Companies to pay $39.5m in OxyContin and Risperdal cases.
    McCarthy M
    BMJ; 2015 Dec; 351():h7018. PubMed ID: 26721284
    [No Abstract]   [Full Text] [Related]  

  • 19. [Risperidone].
    Zolk O; Thürauf N
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1353-6. PubMed ID: 12802745
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
    Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
    Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.